BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34302457)

  • 1. Successful treatment of joint and fascial chronic graft-versus-host disease with baricitinib.
    Shimizu M; Shimbo A; Takagi M; Eguchi K; Ishimura M; Sugita J; Morio T; Kanegane H
    Rheumatology (Oxford); 2021 Dec; 61(1):e1-e3. PubMed ID: 34302457
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of spondyloenchondrodysplasia with baricitinib.
    Shimizu M; Inoue N; Mizuta M; Irabu H; Okajima M; Honda Y; Nihira H; Izawa K; Yachie A; Wada T
    Rheumatology (Oxford); 2021 Feb; 60(2):e44-e46. PubMed ID: 32856090
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis.
    Delvino P; Bartoletti A; Monti S; Biglia A; Montecucco C; Carducci M; Ripamonti G; Cavagna L
    Rheumatology (Oxford); 2020 Dec; 59(12):e125-e127. PubMed ID: 32353871
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of Progression of Acrodermatitis Continua of Hallopeau With Baricitinib.
    Han GM; Yang WS; Yang B
    JAMA Dermatol; 2021 Apr; 157(4):466-468. PubMed ID: 33656520
    [No Abstract]   [Full Text] [Related]  

  • 5. Baricitinib: A chance to treat COVID-19?
    Lo Caputo S; Corso G; Clerici M; Santantonio TA
    J Med Virol; 2020 Nov; 92(11):2343-2344. PubMed ID: 32437019
    [No Abstract]   [Full Text] [Related]  

  • 6. Repigmentation of vitiligo with oral baricitinib.
    Mumford BP; Gibson A; Chong AH
    Australas J Dermatol; 2020 Nov; 61(4):374-376. PubMed ID: 32491188
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome.
    Nousari Y; Wu BC; Valenzuela G
    Clin Exp Dermatol; 2021 Oct; 46(7):1330-1332. PubMed ID: 33914946
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes simplex infection in a patient with rheumatoid arthritis treated with baricitinib: a case report.
    Valor-Méndez L; Voskens C; Rech J; Kleyer A; Schett G
    Rheumatology (Oxford); 2021 Apr; 60(4):e122-e123. PubMed ID: 33141876
    [No Abstract]   [Full Text] [Related]  

  • 9. Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib.
    De Stefano L; Bobbio-Pallavicini F; Montecucco C; Bugatti S
    Rheumatology (Oxford); 2022 Mar; 61(3):e64-e66. PubMed ID: 34647989
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus Enteritis in a Patient with Rheumatoid Arthritis Receiving Baricitinib.
    Sugawara E; Matsui K; Amasaki Y
    J Rheumatol; 2020 Dec; 47(12):1835-1836. PubMed ID: 33262287
    [No Abstract]   [Full Text] [Related]  

  • 11. Baricitinib in Alopecia Areata.
    Messenger A; Harries M
    N Engl J Med; 2022 May; 386(18):1751-1752. PubMed ID: 35507486
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation.
    Diluvio L; Matteini E; Lambiase S; Cioni A; Gaeta Shumak R; Dattola A; Bianchi L; Campione E
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e478-e480. PubMed ID: 38084867
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment.
    Valor-Méndez L; Hagen M; Kleyer A; Manger B; Schett G
    RMD Open; 2020 Nov; 6(3):. PubMed ID: 33214327
    [No Abstract]   [Full Text] [Related]  

  • 14. Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
    Rubin R
    JAMA; 2022 Jun; 327(23):2281. PubMed ID: 35727290
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral Baricitinib Restores Hair Loss in Alopecia Areata.
    Slomski A
    JAMA; 2022 Jun; 327(24):2386. PubMed ID: 35762995
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of generalized granuloma annulare with baricitinib.
    Yan TM; Zhang H; Wu XY; Zhang ZY
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e500-e502. PubMed ID: 35220615
    [No Abstract]   [Full Text] [Related]  

  • 17. Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis.
    Pérez-Alba E; Nuzzolo-Shihadeh L; Aguirre-García GM; Espinosa-Mora J; Lecona-Garcia JD; Flores-Pérez RO; Mendoza-Garza M; Camacho-Ortiz A
    J Microbiol Immunol Infect; 2021 Oct; 54(5):787-793. PubMed ID: 34294593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab-associated facial and neck dermatitis successfully treated with baricitinib.
    Magarreiro-Silva A; Pimenta R; Gouveia AI; Mendes-Bastos P
    J Dtsch Dermatol Ges; 2024 May; 22(5):704-705. PubMed ID: 38470157
    [No Abstract]   [Full Text] [Related]  

  • 19. Widespread soft tissue calcification in systemic sclerosis, polymyositis, and polyarthritis.
    Hudowenz O; Klemm P; Lange U; Mueller-Ladner U
    Lancet; 2021 Jan; 397(10272):409. PubMed ID: 33516339
    [No Abstract]   [Full Text] [Related]  

  • 20. Subclinical, early hair regrowth in alopecia areata patients under treatment with baricitinib detected by line-field confocal optical coherence tomography evaluation.
    Verzì AE; Lacarrubba F; Dall'Oglio F; Rini S; Tosti A; Micali G
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e459-e461. PubMed ID: 37909307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.